Cargando…
miR-122 and hepatocellular carcinoma: from molecular biology to therapeutics
Autores principales: | Fu, Xiao, Calin, George A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284505/ https://www.ncbi.nlm.nih.gov/pubmed/30337246 http://dx.doi.org/10.1016/j.ebiom.2018.10.032 |
Ejemplares similares
-
Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
por: Amr, Khalda S., et al.
Publicado: (2017) -
Circulating microRNAs (miR‐16, miR‐22, miR‐122) expression and early diagnosis of hepatocellular carcinoma
por: Fang, Yujia, et al.
Publicado: (2022) -
Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosis
por: Gumilas, Nur Signa Aini, et al.
Publicado: (2022) -
miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
por: Nassirpour, Rounak, et al.
Publicado: (2013) -
Decreased miR122 in hepatocellular carcinoma leads to chemoresistance
with increased arginine
por: Kishikawa, Takahiro, et al.
Publicado: (2015)